- Home
- MLYS vs MOMO Comparison
MLYS vs MOMO Comparison
Compare MLYS & MOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- MOMO
- Stock Information
- Founded
- MLYS 2019
- MOMO 2011
- Country
- MLYS United States
- MOMO China
- Employees
- MLYS N/A
- MOMO N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- MOMO Computer Software: Prepackaged Software
- Sector
- MLYS Health Care
- MOMO Technology
- Exchange
- MLYS Nasdaq
- MOMO Nasdaq
- Market Cap
- MLYS 1.0B
- MOMO 909.4M
- IPO Year
- MLYS 2023
- MOMO 2014
- Fundamental
- Price
- MLYS $13.67
- MOMO $8.02
- Analyst Decision
- MLYS Strong Buy
- MOMO Buy
- Analyst Count
- MLYS 4
- MOMO 2
- Target Price
- MLYS $27.00
- MOMO $10.00
- AVG Volume (30 Days)
- MLYS 692.8K
- MOMO 1.0M
- Earning Date
- MLYS 08-12-2025
- MOMO 09-02-2025
- Dividend Yield
- MLYS N/A
- MOMO 3.74%
- EPS Growth
- MLYS N/A
- MOMO N/A
- EPS
- MLYS N/A
- MOMO 1.06
- Revenue
- MLYS N/A
- MOMO $1,450,201,337.00
- Revenue This Year
- MLYS N/A
- MOMO $1.04
- Revenue Next Year
- MLYS N/A
- MOMO $3.62
- P/E Ratio
- MLYS N/A
- MOMO $7.57
- Revenue Growth
- MLYS N/A
- MOMO N/A
- 52 Week Low
- MLYS $8.24
- MOMO $5.12
- 52 Week High
- MLYS $18.38
- MOMO $9.22
- Technical
- Relative Strength Index (RSI)
- MLYS 45.18
- MOMO 39.78
- Support Level
- MLYS $13.41
- MOMO $8.38
- Resistance Level
- MLYS $15.15
- MOMO $8.56
- Average True Range (ATR)
- MLYS 0.73
- MOMO 0.22
- MACD
- MLYS 0.01
- MOMO -0.14
- Stochastic Oscillator
- MLYS 25.36
- MOMO 4.00
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About MOMO Hello Group Inc.
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.